Alterations in bcl-2 and caspase gene family protein expression in human temporal lobe epilepsy

Neurology

Volumn 55, Issue 2, 2000, Pages 250-257

  Henshall, D C ^b   Clark, R S B ^b   Adelson, P D ^b   Chen, M ^b   Watkins, S C ^b   Simon, R P ^a  

^a LEGACY RESEARCH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; PROTEIN BCL 2;

ADOLESCENT; ADULT; ANTICONVULSANT THERAPY; ARTICLE; CELL DEATH; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; LOBECTOMY; MALE; NERVE DEGENERATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATOR GENE; TEMPORAL LOBE EPILEPSY;

EID: 0033854412     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.55.2.250     Document Type: Article

References (50)

1. Meldrum BS, Bruton CJ. Epilepsy. In: Adams JH, Duchen LW, eds. Greenfield's neuropathology, 5th ed. New York: Oxford University Press, 1992:1246-1283.
2. Kalviainen R, Salmenpera T, Partanen K, Vainio P, Riekkinen P, Pitkanen A. Recurrent seizures may cause hippocampal damage in temporal lobe epilepsy. Neurology 1998;50:1377-1382.
3. Tasch E, Cendes F, Li LM, Dubeau F, Andermann F, Arnold DL. Neuroimaging evidence of progressive neuronal loss and dysfunction in temporal lobe epilepsy. Ann Neurol 1999;45: 568-576.
4. Pollard H, Charriaut-Marlangue C, Cantagrel S, et al. Kainate-induced apoptotic cell death in hippocampal neurons. Neuroscience 1994;63:7-18.
5. Filipkowski RK, Hetman M, Kaminska B, Kaczmarek L. DNA fragmentation in rat brain after intraperitoneal administration of kainate. NeuroReport 1994;5:1538-1540.
6. Graham SH, Chen J, Stetler RA, Zhu RL, Jin KL, Simon RP. Expression of the proto-oncogene bcl-2 is increased in the rat brain following kainate-induced seizures. Rest Neurol Neurosci 1996;9:243-250.
7. Sloviter RS, Dean E, Sollas AL, Goodman JH. Apoptosis and necrosis induced in different hippocampal neuron populations by repetitive perforant path stimulation in the rat. J Comp Neurol 1996;366:516-533.
8. Zhang LX, Smith MA, Li XL, Weiss SR, Post RM. Apoptosis of hippocampal neurons after amygdala kindled seizures. Mol Brain Res 1998;55:198-208.
9. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998;281:1322-1326.
10. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998;281:1312-1316.
11. Hara H, Friedlander RM, Gagliardini V, et al. Inhibition of interleukin 1-beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc Natl Acad Sci USA 1997;94:2007-2012.
12. Yakovlev AG, Knoblach SM, Fan L, Fox GB, Goodnight R, Faden AI. Activation of CPP32-like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury. J Neurosci 1997;17:7415-7424.
13. Chen J, Nagayama T, Jin K, et al. Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia. J Neurosci 1998; 18:4914-4928.
14. Namura S, Zhu J, Fink K, et al. Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J Neurosci 1998;18:3659-3668.
15. Schielke GP, Yang GY, Shivers BD, Betz AL. Reduced ischemic brain injury in interleukin-1 beta converting enzyme-deficient mice. J Cereb Blood Flow Metab 1998;18:180-185.
16. Gillardon F, Wickert H, Zimmermann M. Up-regulation of bax and down-regulation of bcl-2 is associated with kainate-induced apoptosis in mouse brain. Neurosci Lett 1995;192:85-88.
17. Gillardon F, Bottiger B, Schmitz B, Zimmermann M, Hossmann K-A. Activation of CPP32 protease in hippocampal neurons following ischemia and epilepsy. Mol Brain Res 1997;50: 16-22.
18. Faherty CJ, Xanthoudakis S, Smeyne RJ. Caspase-3-dependent neuronal death in the hippocampus following kainic acid treatment. Mol Brain Res 1999;70:159-163.
19. Clark RS, Kochanek PM, Chen M, et al. Increases in Bcl-2 and cleavage of caspase-1 and caspase-3 in human brain after head injury. FASEB J 1999;13:813-821.
20. Aminoff MJ. Do nonconvulsive seizures damage the brain? -No. Arch Neurol 1998;55:119-120.
21. Sloviter RS, Pedley TA. Subtle hippocampal malformation: importance in febrile seizures and development of epilepsy. Neurology 1998;50:846-984.
22. Young GB, Jordan KG. Do nonconvulsive seizures damage the brain? - Yes. Arch Neurol 1998;55:117-119.
23. Salmenpera T, Kalviainen R, Partanen K, Pitkanen A. Hippocampal damage caused by seizures in temporal lobe epilepsy. Lancet 1998;351:35.
24. Sloviter RS. "Epileptic" brain damage in rats induced by sustained electrical stimulation of the perforant path. I. Acute electrophysiological and light microscopic studies. Brain Res Bull 1983;10:675-697.
25. Olney JW, deGubareff T, Sloviter RS. "Epileptic" brain damage in rats induced by sustained electrical stimulation of the perforant path. II. Ultrastructural analysis of acute hippocampal pathology. Brain Res Bull 1983;10:699-712.
26. Allsopp TE, Wyatt S, Paterson HF, Davies AM. The protooncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell 1993;73:295-307.
27. Martinou JC, Dubois-Dauphin M, Staple JK, et al. Overexpression of bcl-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 1994;13:1017-1030.
28. Yang J, Liu X, Bhalla K, et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 1997;275:1129-1132.
29. Chen J, Graham SH, Nakayama M, et al. Apoptosis repressor genes Bcl-2 and Bcl-x-long are expressed in the rat brain following global ischemia. J Cereb Blood Flow Metab 1997;17: 2-10.
30. Clark RS, Chen J, Watkins SC, et al. Apoptosis-suppressor gene bcl-2 expression after traumatic brain injury in rats. J Neurosci 1997;17:9172-9182.
31. Lopez E, Pozas E, Rivera R, Ferrer I. Bcl-2, Bax and Bcl-x expression following kainic acid administration at convulsant doses in the rat. Neuroscience 1999;91:1461-1470.
32. L-specific antibody labels activated microglia associated with Alzheimer's disease and other pathological states. J Neurosci Res 1997;47:98-108.
33. Hawrylak N, Chang F, Greenough W. Astrocytic and synaptic response to kindling in hippocampal subfield CAl. II. Synaptogenesis and astrocytic process increases to in vivo kindling. Brain Res 1993;603:309-316.
34. Aschner M. Astrocytic functions and physiological reactions to injury: the potential to induce and/or exacerbate neuronal dysfunction. Neurotoxicology 1998;19:7-17.
35. Spencer SS, Kim J, deLanerolle N, Spencer DD. Differential neuronal and glial relations with parameters of ictal discharge in mesial temporal lobe epilepsy. Epilepsia 1999;40: 708-712.
36. Du F, Williamson J, Bertram E, Lothman E, Okuno E, Schwarcz R. Kynurenine pathway enzymes in a rat model of chronic epilepsy: immunohistochemical study of activated glial cells. Neuroscience 1993;55:975-989.
37. Niquet J, Ben-Ari Y, Represa A. Glial reaction after seizure induced hippocampal lesion: immunohistochemical characterization of proliferating glial cells. J Neurocytol 1994;23:641-656.
38. Wolter KG, Hsu YT, Smith CL, Nechushtan A, Xi XG, Youle RJ. Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol 1997;139:1281-1292.
39. Gross A, Jockel J, Wei MC, Korsmeyer SJ. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J 1998;17:3878-3885.
40. Thornberry NA, Bull HG, Calaycay JR, et al. A novel heterodimeric cysteine protease is required for interleukin-1B processing in monocytes. Nature 1992;356:768-774.
41. Eriksson C, Van Dam AM, Lucassen PJ, Bol JG, Winbald B, Schultzberg M. Immunohistochemical localization of interleukin 1beta, interleukin-1 receptor antagonist and interleukin-1beta converting enzyme/caspase-1 in the rat brain after peripheral administration of kainic acid. Neuroscience 1999; 93:915-930.
42. Fernandes-Alnemri T, Litwack G, Alnemri ES. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J Biol Chem 1994;269: 30761-30764.
43. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998;391:43-50.
44. Mathern GW, Pretorius JK, Kornblum HI, et al. Human hippocampal AMPA and NMDA mRNA levels in temporal lobe epilepsy patients. Brain 1997;120:1937-1959.
45. Dournaud P, Cervera-Pierot P, Hirsch E, et al. Somatostatin messenger RNA-containing neurons in Alzheimer's disease: an in situ hybridization study in hippocampus, parahippocampal cortex and frontal cortex. Neuroscience 1994;61:755-764.
46. Wetzel DM, Bohn MC, Hamill RW. Postmortem stability of mRNA for glucocorticoid and mineralocorticoid receptor in rodent brain. Brain Res 1994;649:117-121.
47. Gonzalez-Garcia M, Garcia I, Ding L, et al. Bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death. Proc Natl Acad Sci USA 1995;92: 4304-4308.
48. Kane DJ, Ord T, Anton R, Bredesen DE. Expression of bcl-2 inhibits necrotic neural cell death. J Neurosci Res 1995;40: 269-275.
49. Borner C, Monney L. Apoptosis without caspases: an inefficient molecular guillotine? Cell Death Diff 1999;6:497-507.
50. Kitanaka C, Kuchino Y. Caspase-independent programmed cell death with necrotic morphology. Cell Death Diff 1999;6: 508-515.